Treffen Sie uns an den folgenden Veranstaltungen

Die Speed-Datings bieten eine internationale Plattform um Pharma-Akteure zusammenzubringen. Während den persönlichen Network-Meetings können Sie neue Kontakte knüpfen mit Business Partnern Ihrer Wahl. 

Profitieren Sie von unserem langjährigen Knowhow als Schweizer Pharma Lohnhersteller und tauschen Sie sich mit unserem Business Development Team über Ihre zukünftigen Projekte und Ideen aus. An folgenden Pharma Business Partnering & Networking Events treffen Sie uns dieses Jahr an: 

2. März – 3. März 2026: EUR PLX Cascais

22. März – 26. März 2026: DCAT New York

16. April – 17. April 2026: Europharm Berlin

10. – 12. Mai 2026: Swiss HLG Montreux

08. – 09. Juni 2026: EUR PLX Warschau

22. – 23. September 2026: Pharma Synergy Rome

06. – 08. Oktober 2026: CPHI, Mailand

16. – 17. November 2026: EUR PLX Rome


Wir freuen uns darauf, gemeinsam mit Ihnen neue Impulse für die Branche zu setzen und Ihre Ideen zu hören.

Heidrun Goth, Business Development Manager Pharma
«Möchten Sie bereits vorab einen Termin mit uns vereinbaren? Ich stehe Ihnen gerne zur Verfügung.»
Maciej Libort, Business Development Manager Pharma
«Möchten Sie bereits vorab einen Termin mit uns vereinbaren? Ich stehe Ihnen gerne zur Verfügung.»
Share article

Come meet us at the following events

The speed dating events provide an international platform for bringing together players in the pharmaceutical industry. During the in-person networking sessions, you can make new connections with business partners of your choice.

Take advantage of our many years of expertise as a Swiss contract manufacturer in the pharmaceutical industry and discuss your future projects and ideas with our Business Development Team. You can meet us at the following pharmaceutical business partnering and networking events this year:

September 22–23, 2026: Pharma Synergy Rome

October 6–8, 2026: CPHI, Milan

November 16–17, 2026: EUR PLX Rome

We look forward to working with you to bring fresh ideas to the industry and to hearing your ideas.

Heidrun Goth, Business Development Manager Pharma
«Would you like to schedule an appointment with us in advance? I'd be happy to assist you.»
Maciej Libort, Business Development Manager Pharma
«Would you like to schedule an appointment with us in advance? I'd be happy to assist you.»
Share article

Your Highlights at the Trade Show

  • Discover our wide selection of pharmaceutical products, ranging from liquids to semi-solids. Our trade show team will demonstrate our extensive manufacturing and filling options, as well as specialized technologies such as emulsion processing.
  • A New Face in Sales: Meet our new Head of Business Development Pharma, Peter Näf, in person.
  • Trade Show Team on Site: André Keller (CEO), Felix Burkhart (Head of the Pharma Business Unit), Peter Näf (Head of Business Development, Pharma), Heidrun Goth (Business Development Manager, Pharma), Maciej Libort (Business Development Manager, Pharma), Niklas Stroh (Pharmaceutical Formulation Developer), Karsten Schlaeger (Head of Purchasing)

Let's talk about your ideas

Take advantage of our many years of expertise as a Swiss contract manufacturer and discuss your current projects and ideas with our trade show team. Visit us in Hall 12 at Booth M11—daily from 10:00 a.m. to 6:30 p.m.

Tuesday, October 6, 2026: 10:00 a.m. – 6:30 p.m.
Wednesday, October 7, 2026: 10:00 a.m. – 6:30 p.m.
Thursday, October 8, 2026: 10:00 a.m. – 4:00 p.m.

Sounds exciting? We look forward to welcoming you to Milan soon.

New Leadership in Business Development

Meet our new Head of Business Development in person! Peter Näf joined our pharmaceutical team in January 2026. As a process engineer, he serves as the ideal link between customers and production. With many years of international experience in the lab tech industry as a supplier to the pharmaceutical sector, he understands customer needs and knows what matters most in long-term partnerships. His career to date has been shaped by international business and market development as well as technical consulting.

In his new role, he leads an experienced team that supports customers from the initial inquiry through to a long-term partnership. His focus is on positioning the strengths of our locations—development, manufacturing, and bottling—even more prominently in the market and establishing new partnerships. He is particularly looking forward to direct interaction with customers and to projects that combine technical expertise with entrepreneurial thinking. We’re thrilled to have him on board!

Your Swiss Contract Manufacturer for Pharmaceuticals

With 40 years of expertise as a contract manufacturer in the pharmaceutical industry, the FRIKE GROUP is one of Europe’s leading specialists. We use our process mixers, with capacities ranging from 2.5 to 3,000 kg, to manufacture non-sterile, semi-solid, and liquid formulations, as well as suppositories. Thanks to our wide range of mixer sizes, we can scale up production to your desired batch size. Our diverse solutions and expertise also set us apart when it comes to packaging and filling.

Whether you’re planning very small or large-scale production campaigns, developing new formulations, or looking to optimize your existing ones, we are your trusted partner. In every collaboration, we prioritize efficiency, innovation, confidentiality, and customer service above all else.

Heidrun Goth, Business Development Manager Pharma
«Would you like to schedule an appointment with us at CPHI in advance? I'd be happy to assist you.»
Share article

Come meet us at the following events

The speed dating events provide an international platform for bringing together players in the pharmaceutical industry. During the in-person networking sessions, you can make new connections with business partners of your choice.

Take advantage of our many years of expertise as a Swiss contract manufacturer in the pharmaceutical industry and discuss your future projects and ideas with our Business Development Team. You can meet us at the following pharmaceutical business partnering and networking events this year:

September 22–23, 2026: Pharma Synergy Rome

October 6–8, 2026: CPHI, Milan

November 16–17, 2026: EUR PLX Rome

We look forward to working with you to bring fresh ideas to the industry and to hearing your ideas.

Heidrun Goth, Business Development Manager Pharma
«Would you like to schedule an appointment with us in advance? I'd be happy to assist you.»
Maciej Libort, Business Development Manager Pharma
«Would you like to schedule an appointment with us in advance? I'd be happy to assist you.»
Share article

A Request with Consequences

Gebro Pharma and the FRIKE GROUP have known each other for years, not least through their joint involvement in the industry association VIPS, where CEO Marcel Plattner serves as chairman. At the end of 2023, Gebro made an inquiry that changed everything: Their long-standing manufacturer in Canada had been sold, and production of the proven Pennsaid gel had been halted. Without a new partner, a supply disruption loomed — a risk that would have had immediate, tangible consequences in Switzerland.

How the FRIKE GROUP brought Pennsaid gel from Canada back to Switzerland and obtained approval from Swissmedic.

Why Pennsaid isn't a standard product

It quickly became clear that the transfer would be far more than just routine work. Pennsaid gel contains a high concentration of dimethyl sulfoxide (DMSO), a highly potent solvent that corrodes plastics, rendering hoses, seals, and standard components unusable. Added to this is the packaging: an airless bottle with an aluminum pouch that is filled under positive pressure — a process that works reliably only with a specially developed nozzle.

Taking new paths, step by step

After a thorough risk analysis, we decided to take on the project. We adapted the manufacturing specifications to our equipment, designed a custom filling nozzle, and tested several technical variations until the filling process ran smoothly. At the same time, we searched worldwide for DMSO suitable for pharmaceutical use. Although an initial supplier provided compliant product, its stability was insufficient: over time, the raw material developed an onion-like odor. Together with Gebro, we finally found a supplier that met the quality requirements.

Transfer, validation, and final approval

With the supply chain secured, the actual product transfer began. We developed new testing methods, optimized the processing of the challenging excipient, and produced three validation batches. Each batch was thoroughly tested until all quality parameters were consistently and reproducibly met.

A significant moment for both companies

Swissmedic recently approved the change of manufacturer. The first batch for the Swiss market has already been released — a milestone that caps off many months of detailed technical work.

For Gebro Pharma AG and FRIKE GROUP, this project is more than just a successful technology transfer initiative. It demonstrates how two Swiss companies are working together to tackle a complex challenge and make an important medication available again.

Maciej Libort, Business Development Manager Pharma
«Sounds exciting? Let’s talk about your ideas and upcoming projects!»

Discover our product range

As a contract manufacturer of pharmaceuticals, we are your partner for over-the-counter and prescription pharmaceuticals, ranging from liquids and gels to oils. Thanks to our broad expertise and a wide variety of packaging options and formulations, we can meet all your needs.

Watch now
Share article

Your highlights at the trade fair

  • Discover our wide range of pharmaceutical products, from liquid to semi-solid. Our trade fair team will show you our extensive manufacturing and filling options, as well as specialized technologies such as emulsion processing.
  • New face in development: Meet our new Head of Pharmaceutical Development, Niklas Stroh, in person.
  • New trade fair design: In keeping with the new website, our stand has also been given a makeover and now shines in new splendor.

Let's talk about your ideas

Benefit from our many years of expertise as a Swiss contract manufacturer and discuss your current projects and ideas with our trade fair team. Visit us in Hall 6 at Stand 0B15 – from 10:00 a.m. to 6:30 p.m. each day.

October 28: 10:00 a.m. – 6:30 p.m.
October 29: 10:00 a.m. – 6:30 p.m.
October 30: 10:00 a.m. – 4:00 p.m.

Sounds exciting? We look forward to welcoming you soon in Frankfurt.

A breath of fresh air in development

Meet our new Head of Development in person! Niklas Stroh joined our team in August 2024 as a galenic developer in the pharmaceuticals division. As a pharmacist with a master's degree in Pharmaceutical Sciences and Technologies and experience in drug development, he brings with him a wealth of expertise. He gained valuable practical experience working as a pharmacist and in the pharmaceutical industry. With his passion for advanced drug forms and his enthusiasm for tinkering and optimizing, he is an ideal addition to the development department in the pharmaceutical sector. We look forward to many exciting projects that we will be able to realize together with existing and new customers!

Your Swiss pharmaceutical contract manufacturer

With 40 years of expertise as a pharmaceutical contract manufacturer, the FRIKE GROUP is one of Europe’s leading specialists in this area. We use process mixers from 2.5 to 3000 liters to manufacture non-sterile, semi-solid and liquid formulations and suppositories. Thanks to our wide range of mixers, we are well set up to develop new formulations, including scale-up to the batch size you require. We also have impressive, wide-ranging solutions and expertise when it comes to packaging and filling.

Whether you are planning a production campaign, large or small, want to have new formulations developed or optimize your existing ones, we are your expert partner. In every collaboration, efficiency, innovation, confidentiality and customer friendliness are our top priorities.

Heidrun Goth, Business Development Manager Pharma
«Would you like to schedule an appointment with us at CPHI in advance? I am happy to assist you.»
Share article

CPHI 2024 in Milan was a great success for us and a significant milestone in the further development of our business activities. As every year, we were there with an impressive booth and a highly motivated crew.

The entire event was marked by intensive customer discussions and valuable encounters. Our highly motivated Business Development team had the opportunity to deepen many existing partnerships while also making exciting new connections that offer promising prospects for the future.

A special highlight of the week was the customer event on Tuesday evening. In a relaxed atmosphere, we were able to engage in open discussions with long-term partners and new prospects, sharing ideas and gaining valuable insights into future needs and trends in the industry. The positive response to this evening reinforces our approach to fostering close relationships with our clients not only on a business level but also on a personal one.

The only thing that didn't cooperate was the weather. Especially on the first day of the event, we got completely drenched on the way there, and some were glad they packed extra clothes. 😊

We are already looking forward with great anticipation to CPHI 2025 in Frankfurt, where we will once again have the opportunity to strengthen our global partnerships and discover new business opportunities.

We thank everyone who made CPHI 2024 an unforgettable experience and look forward to seeing you in Frankfurt 2025!

 

Best regards,

Benjamin Spitteler, Sales Director BU Pharma

Share article

Visit us at the CPHI in Milan, October 8-10, 2024

One of the largest pharmaceutical trade fairs in Europe is about to begin again, and as always, we will be there with our booth.

Visit us in Hall 7, Booth No. 7D74, and let's talk about future projects.

We look forward to hearing from you.

Your FRIKE Pharma Team

Share article

Scale-up to a new level

Whereas it was previously possible for air inclusions or insufficient homogenisation to impair the tests, the new Mini offers the full range of possibilities of a production mixer. This means that reliable data is already at a new level during development for later scale-up.

This puts FRIKE in a position to support new development projects even more competently, as the new Mini is a mixer of the latest generation. It has a high-shear homogeniser with a circuit that reflects all the dosing applications of a large-scale plant. In addition, the mixer has a memory that continuously logs the parameters travelled. This enables exact comparisons of the tests carried out.

Ultimately, the fact that the new Becolab Mini is the first qualified system of its kind at FRIKE is a decisive factor for us. It can be used to prepare small quantities under GMP production conditions, which can be used in clinical trials, for example. It has already passed its baptism of fire with the first test batches, and the first projects under GMP conditions are under discussion.

What is the role of the person with technical responsibility?

«Medicines are regulated by the authorities, so they are subject to high quality requirements and must be safe for patients. The person with technical responsibility has a bridging function between the regulatory requirements in the manufacture of medicinal products and the internal implementation of these regulations. This ensures that regulatory requirements are also applied in the company and that all products meet the high quality requirements. In this context, the person with technical responsibility also acts as an interface between the authorities and the company.»

What tasks does this person typically perform?

The most important requirement – ensuring high product quality – is set out in the GMP guideline. People often assume that these letters must relate to large tomes of information or the endless quantities of documents out there. In fact, the letters stand for Good Manufacturing Practice and describe what this means for medicinal products. GMP is mandatory for the pharmaceutical industry worldwide and must therefore also be integrated into our own processes.

Success with teamwork

A typical task for a person with technical responsibility is to monitor the implementation of this quality standard in the company. Of course, this can only be achieved with the support of a highly qualified and motivated team that actively evaluates, implements and finally archives the large quantities of paper. Another typical task relates to the release of medicinal products. Since the responsibility for correct production lies with the person with technical responsibility, they are in charge of releasing products and thus confirming that production has been carried out according to GMP.

Why did you choose the FRIKE GROUP as your new employer?

«With around 300 employees, the FRIKE GROUP is one of the largest contract manufacturers in Switzerland. I appreciate being part of the set-up of a large manufacturer with a broad product range and lots of interesting products, as it means exciting projects and challenging tasks. At the same time, I like the informal working environment of FRIKE PHARMA AG, as a small company. Thanks to the manageable size of the company, my tasks are very varied and range from team management to the implementation of the GMP guidelines and the release of medicinal products as the person with technical responsibility. That won me over, and I’m looking forward to taking on many new challenges.»

Share article